These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6333828)

  • 21. Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression.
    Grossman R; Yehuda R; New A; Schmeidler J; Silverman J; Mitropoulou V; Sta Maria N; Golier J; Siever L
    Am J Psychiatry; 2003 Jul; 160(7):1291-8. PubMed ID: 12832244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte function in major depressive disorder.
    Schleifer SJ; Keller SE; Meyerson AT; Raskin MJ; Davis KL; Stein M
    Arch Gen Psychiatry; 1984 May; 41(5):484-6. PubMed ID: 6609689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
    Birmaher B; Dahl RE; Ryan ND; Rabinovich H; Ambrosini P; al-Shabbout M; Novacenko H; Nelson B; Puig-Antich J
    Am J Psychiatry; 1992 Aug; 149(8):1040-5. PubMed ID: 1636803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of weight loss on the dexamethasone suppression test.
    Edelstein CK; Roy-Byrne P; Fawzy FI; Dornfeld L
    Am J Psychiatry; 1983 Mar; 140(3):338-41. PubMed ID: 6829806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cortisol suppression index and the dexamethasone suppression test in major depression.
    Maes M; De Ruyter M; Suy E
    Acta Psychiatr Belg; 1987; 87():633-9. PubMed ID: 3452982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
    Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4 p.m. baseline cortisol level as a predictor of DST results in depression.
    Weiler MA; Jobe TH; Nasr SJ; Pandey G; Altman EG
    J Clin Psychiatry; 1986 Feb; 47(2):60-2. PubMed ID: 3944064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of the dexamethasone suppression test to subtypes of depression and to symptomatic severity in the elderly.
    Georgotas A; Stokes PE; Hapworth WE; Kim OM; Fanelli C; Stoll PM; Sinaiko E; McCue RE
    J Affect Disord; 1986; 10(1):51-7. PubMed ID: 2939123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortisol level response to 1- and 2-mg doses of dexamethasone.
    Brown WA; Daamen M; D'Agostino C; Dockery EL; Fournier PA; Parsells AH
    Am J Psychiatry; 1983 May; 140(5):609-11. PubMed ID: 6846593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of the cortisol suppression index in depression.
    Bernstein JP; Chung SY
    J Clin Psychiatry; 1984 Oct; 45(10):433-6. PubMed ID: 6480569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects.
    Amsterdam JD; Winokur A; Caroff SN; Conn J
    Am J Psychiatry; 1982 Mar; 139(3):287-91. PubMed ID: 7058940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects.
    Amsterdam JD; Winokur A; Abelman E; Lucki I; Rickels K
    Am J Psychiatry; 1983 Jul; 140(7):907-9. PubMed ID: 6305216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function.
    Fauci AS
    Clin Exp Immunol; 1976 Apr; 24(1):54-62. PubMed ID: 1084818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DST and TRH stimulation test in mood disorder subtypes.
    Levy AB; Stern SL
    Am J Psychiatry; 1987 Apr; 144(4):472-5. PubMed ID: 3105335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased plasma MHPG in dexamethasone-resistant depressed patients.
    Jimerson DC; Insel TR; Reus VI; Kopin IJ
    Arch Gen Psychiatry; 1983 Feb; 40(2):173-6. PubMed ID: 6824413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
    Maes M; Bosmans E; Meltzer HY; Scharpé S; Suy E
    Am J Psychiatry; 1993 Aug; 150(8):1189-93. PubMed ID: 8328562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dexamethasone suppression test and unipolar/bipolar distinctions.
    Zisook S; Janowsky DS; Overall JE; Risch SC
    J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.